Literature DB >> 16931997

Inhaled nitric oxide for treatment of sickle cell stroke.

Pedro Montero-Huerta1, Dean R Hess, C Alvin Head.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16931997     DOI： 10.1097/00000542-200609000-00028

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  2 in total

1.  Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice.

Authors:  Camila Bononi Almeida; Christoph Scheiermann; Jung-Eun Jang; Colette Prophete; Fernando Ferreira Costa; Nicola Conran; Paul S Frenette
Journal:  Blood       Date:  2012-07-25       Impact factor: 22.113

Review 2.  Biologic complexity in sickle cell disease: implications for developing targeted therapeutics.

Authors:  Beatrice E Gee
Journal:  ScientificWorldJournal       Date:  2013-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.